TriMas (TRS) investor relations material

Executive summary

• Q3 continuing-operations sales rose 7.7% YoY to $178.7M, driven by organic growth in Packaging and Specialty Products and favorable FX.

• Adjusted operating profit increased 47.9% to $13.6M; adjusted diluted EPS rose 194.1% to $0.50, supported by cost actions, interest income and lower share count.

• Norris Cylinder throughput challenges constrained Specialty Products results, while leadership and operational initiatives advanced.

Financial highlights

• Q3 adjusted operating margin was 7.6%, up 200 bps YoY; adjusted operating profit was $13.6M versus $9.2M.

• First-nine-month sales increased 6.4% to $521.6M; adjusted operating profit rose 35.8% to $41.2M and adjusted EPS increased from $0.51 to $1.25.

• Q3 GAAP income from continuing operations was $13.5M versus a $4.9M loss; consolidated net income was $19.4M, including $5.9M from discontinued operations.

• Adjusted free cash flow was $20.9M versus $4.0M YoY; GAAP operating cash flow from continuing operations was $(66.7)M.

Outlook and guidance

• FY26 adjusted diluted EPS guidance was reaffirmed at $1.60–$1.70; sales growth guidance was raised to 4%–6% and adjusted operating margin expansion remains ~250 bps.

• Packaging FY sales growth is expected at 4%–5%, with operating margin near 14%, including the expected Rapak sale impact.

• Specialty Products FY sales growth is expected at 7%–10%, with operating margin now forecast at 4%–6% amid manufacturing and productivity challenges.

• Q4 sales, earnings and EPS are expected to improve YoY; Q4 interest income is estimated at $10M, assuming no significant rate changes or cash redeployment.

• FY26 interest expense is expected at $18M, the effective tax rate at 24%–25%, and corporate cash expenses to decline $11M–$12M YoY.